Brief: EQL Pharma Q4 EBIT Margin at 10%

EQL Pharma AB

11/05/2023 06:51

May 11 (Reuters) - EQL Pharma Q4 EBIT SEK 6.1 million.
* Q4 adjusted free cash flow SEK 18.2 million
* Q4 adjusted revenue SEK 53.5 million
* Q4 revenue SEK 60.3 million